Human IL-6 R alpha Quantikine PharmPak (50 Plates)

• Supplier: R&D Systems
• Catalog: PDR600
• Category: ELISA Kit
• Assay Type: Solid Phase Sandwich ELISA
• Sample Type: Cell Culture Supernates (100 µL), Serum (10 µL), EDTA Plasma (10 µL), Heparin Plasma (10 µL), Citrate Plasma (10 µL), Urine (50 µL)
• Sensitivity: 15.1 pg/mL
• Range: 31.2 - 2,000 pg/mL (Serum, Heparin Plasma, Cell Culture Supernates, Citrate Plasma, EDTA Plasma, Urine)
• Format: 96-well strip plate
• Description: The Quantikine Human IL-6 sR Immunoassay is a 4.5 hour solid phase ELISA designed to measure human IL-6 sR in cell culture supernates, serum, plasma, and urine
• Gene: IL6R

Product References

Inflammatory markers and the risk of hip fracture: the Women's Health Initiative. - Inflammatory markers and the risk of hip fracture: the Women's Health Initiative.

Barbour KE, Boudreau R, Danielson ME, Youk AO, Wactawski-Wende J, Greep NC, LaCroix AZ, Jackson RD, Wallace RB, Bauer DC, Allison MA, Cauley JA. J Bone Miner Res. 2012 May;27(5):1167-76.

Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor - Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor

Tai YT, Chang BY, Kong SY, Fulciniti M, Yang G, Calle Y, Hu Y, Lin J, Zhao JJ, Cagnetta A, Cea M, Sellitto MA, Zhong MY, Wang Q, Acharya C, Carrasco DR, Buggy JJ, Elias L, Treon SP, Matsui W, Richardson P, Munshi NC, Anderson KC. Blood. 2012 Aug 30;120(9):1877-87.

Maternal country of origin, breast milk characteristics and potential influences - Maternal country of origin, breast milk characteristics and potential influences

Holmlund U, Amoudruz P, Johansson MA, Haileselassie Y, Ongoiba A, Kayentao K, Traore B, Doumbo S, Schollin J, Doumbo O, Montgomery SM, Sverremark-Ekstrom E. Clin Exp Immunol. 2010 Dec;162(3):500-9.

Interleukin-6 in the bone marrow microenvironment promotes the growth and - Interleukin-6 in the bone marrow microenvironment promotes the growth and

Ara T, Song L, Shimada H, Keshelava N, Russell HV, Metelitsa LS, Groshen SG, Seeger RC, DeClerck YA. Cancer Res. 2009 Jan 1;69(1):329-37.

Soluble and membrane levels of molecules involved in the interaction between - Soluble and membrane levels of molecules involved in the interaction between

Perez-Andres M, Almeida J, Martin-Ayuso M, De Las Heras N, Moro MJ, Martin-Nunez G, Galende J, Cuello R, Abuin I, Moreno I, Dominguez M, Hernandez J, Mateo G, San Miguel JF, Orfao A. Int J Cancer. 2009 Jan 15;124(2):367-75.

Daily family assistance and inflammation among adolescents from Latin American - Daily family assistance and inflammation among adolescents from Latin American

Fuligni AJ, Telzer EH, Bower J, Irwin MR, Kiang L, Cole SW. Brain Behav Immun. 2009 Aug;23(6):803-9.

Functional interaction of plasmacytoid dendritic cells with multiple myeloma - Functional interaction of plasmacytoid dendritic cells with multiple myeloma

Chauhan D, Singh AV, Brahmandam M, Carrasco R, Bandi M, Hideshima T, Bianchi G, Podar K, Tai YT, Mitsiades C, Raje N, Jaye DL, Kumar SK, Richardson P, Munshi N, Anderson KC. Cancer Cell. 2009 Oct 6;16(4):309-23.

Urinary proinflammatory cytokine response in renal transplant recipients with - Urinary proinflammatory cytokine response in renal transplant recipients with

Sadeghi M, Daniel V, Schnitzler P, Lahdou I, Naujokat C, Zeier M, Opelz G. Transplantation. 2009 Nov 15;88(9):1109-16.

Improved prediction of disease relapse after radical prostatectomy through a - Improved prediction of disease relapse after radical prostatectomy through a

Shariat SF, Karam JA, Walz J, Roehrborn CG, Montorsi F, Margulis V, Saad F, Slawin KM, Karakiewicz PI. Clin Cancer Res. 2008 Jun 15;14(12):3785-91.

Interleukin-6 and soluble interleukin-6 receptor levels as markers of disease - Interleukin-6 and soluble interleukin-6 receptor levels as markers of disease

Egler RA, Burlingame SM, Nuchtern JG, Russell HV. Clin Cancer Res. 2008 Nov 1;14(21):7028-34.